Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2017 (824 publications)

no pagination
Giorgi A, Tempera I, Napoletani G, Drovandi D, Potesta C, Martire S, Mandosi E, Filardi T, Eugenia Schinina M, Morano S, d'Erme M, Maras B. Poly(ADP-ribosylated) proteins in mononuclear cells from patients with type 2 diabetes identified by proteomic studies. Acta diabetologica. 2017 Sep;54(9):833-42.
Goldstein LJ, Zhao F, Wang M, Swaby RF, Sparano JA, Meropol NJ, Bhalla KN, Pellegrino CM, Katherine Alpaugh R, Falkson CI, Klein P, Sledge GW. A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104). Breast Cancer Res Treat. 2017 Sep;165(2):375-82.   PMCID: PMC5682621
Gutierrez Diez PJ, Su Y, Russo J. Immunocytochemical stem cell markers can predict clinical stage of breast cancer. Oncology reports. 2017 Sep;38(3):1507-16.
Gutierrez Diez PJ, Su Y, Russo J. Immunocytochemical stem cell markers can predict clinical stage of breast cancer. Oncology reports. 2017 Sep;38(3):1507-16.
Haas NB, Manola J, Dutcher JP, Flaherty KT, Uzzo RG, Atkins MB, DiPaola RS, Choueiri TK. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. JAMA Oncol. 2017 Sep;3(9):1249-52.   PMCID: PMC5591751
Hensley ML, Patel SR, von Mehren M, Ganjoo K, Jones RL, Staddon A, Rushing D, Milhem M, Monk B, Wang G, McCarthy S, Knoblauch RE, Parekh TV, Maki RG, Demetri GD. Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial. Gynecol Oncol. 2017 Sep;146(3):531-7.
King KM, Myers AM, Soroka-Monzo AJ, Tuma RF, Tallarida RJ, Walker EA, Ward SJ. Single and combined effects of Delta(9) -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain. British journal of pharmacology. 2017 Sep;174(17):2832-41.   PMCID: PMC5554313
Krais JJ, Virani N, McKernan PH, Nguyen Q, Fung KM, Sikavitsas VI, Kurkjian C, Harrison RG. Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide. Molecular Cancer Therapeutics. 2017 Sep;16(9):1855-65.
Lee M, Zhu L, Wang MQ, Wei Z, Tan Y, Nguyen MT, Ogunwobi OO, Ma GX. Psychosocial Predictors of HBV Screening Behavior among Vietnamese Americans. American journal of health behavior. 2017 Sep;41(5):561-70.   PMCID: PMC5633084
Li K, Wen M, Henry KA. Ethnic density, immigrant enclaves, and Latino health risks: A propensity score matching approach. Social science & medicine (1982). 2017 Sep;189:44-52.   PMCID: PMC5573190
Liu H, Sun Q, Sun Y, Zhang J, Yuan H, Pang S, Qi X, Wang H, Zhang M, Zhang H, Yu C, Gu C. MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation. Molecular cancer research : MCR. 2017 Sep;15(9):1275-86.
Liu X, Li YS, Shinton SA, Rhodes J, Tang L, Feng H, Jette CA, Look AT, Hayakawa K, Hardy RR. Zebrafish B Cell Development without a Pre-B Cell Stage, Revealed by CD79 Fluorescence Reporter Transgenes. J Immunol. 2017 Sep;199(5):1706-15.   PMCID: PMC5563169
Mennis J, Mason M, Ambrus A, Way T, Henry K. The spatial accuracy of geographic ecological momentary assessment (GEMA): Error and bias due to subject and environmental characteristics. Drug and alcohol dependence. 2017 Sep;178:188-93.
Nizovtseva EV, Todolli S, Olson WK, Studitsky VM. Towards quantitative analysis of gene regulation by enhancers. Epigenomics. 2017 Sep;9(9):1219-31.   PMCID: PMC5585842
Obeid EI, Hall MJ, Daly MB. Multigene Panel Testing and Breast Cancer Risk: Is It Time to Scale Down?. JAMA Oncol. 2017 Sep;3(9):1176-7.
Patt YZ, Murad W, Fekrazad MH, Baron AD, Bansal P, Boumber Y, Steinberg K, Lee SJ, Bedrick E, Du R, Lee FC. INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial. Cancer medicine. 2017 Sep;6(9):2042-51.   PMCID: PMC5603839
Reese JB, Lepore SJ, Handorf EA, Haythornthwaite JA. Emotional approach coping and depressive symptoms in colorectal cancer patients: The role of the intimate relationship. Journal of psychosocial oncology. 2017 Sep;35(5):578-96.   PMCID: PMC5804335
Roche LM, Niu X, Stroup AM, Henry KA. Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis. Journal of public health management and practice : JPHMP. 2017 Sep;23(5):477-86.   PMCID: PMC5548504
Simmons RA, Cosgrove SC, Romney MC, Plumb JD, Brawer RO, Gonzalez ET, Fleisher LG, Moore BS. Health Literacy: Cancer Prevention Strategies for Early Adults. Am J Prev Med. 2017 Sep;53(3s1):S73-s77.
Thompson MD, Lubet RA, McCormick DL, Clapper ML, Bode AM, Juliana MM, Moeinpour F, Grubbs CJ. Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer. Oncology Letters. 2017 Sep;14(3):3480-6.   PMCID: PMC5587978
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2017


Last updated on Tuesday, June 05, 2018